JanOne Inc. (NASDAQ:JAN – Get Free Report)’s share price traded down 5.6% during mid-day trading on Tuesday . The stock traded as low as $1.97 and last traded at $2.02. 66,620 shares were traded during trading, a decline of 71% from the average session volume of 231,072 shares. The stock had previously closed at $2.14.
JanOne Price Performance
The business’s fifty day moving average price is $3.09 and its two-hundred day moving average price is $2.12.
JanOne (NASDAQ:JAN – Get Free Report) last announced its quarterly earnings data on Friday, May 3rd. The company reported ($0.34) EPS for the quarter.
About JanOne
JanOne Inc, a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through Biotechnology and Recycling segments.
Read More
- Five stocks we like better than JanOne
- Financial Services Stocks Investing
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- 3 Warren Buffett Stocks to Buy Now
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Which Wall Street Analysts are the Most Accurate?
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
Receive News & Ratings for JanOne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JanOne and related companies with MarketBeat.com's FREE daily email newsletter.
